Jyong Biotech Ltd. - Ordinary shares

Share · KYG831161065 · MENS (XNAS)

No Price

29.01.2026 00:40

Current Prices from Jyong Biotech Ltd. - Ordinary shares

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	MENS	USD	29.01.2026 00:40	2,53 USD	0,00 USD

Company Profile for Jyong Biotech Ltd. - Ordinary shares Share

Jyong Biotech Ltd. is a Taiwan-based biotech firm focused on developing and commercializing plant-derived drugs targeting urinary system diseases. The company operates through its subsidiaries—Health Ever Bio-Tech, Genvace, and others—working on drug candidates like MCS‑2 (for BPH) currently in Phase III, PCP (for prostate cancer) in Phase II, and IC in pre-clinical stages

AI Analysis of Jyong Biotech Ltd. - Ordinary shares

Click any analysis below to get instant AI insights from finAgent

Latest AI Analyses of Jyong Biotech Ltd. - Ordinary shares

No AI threads available for this company yet.

Company Data

Name Jyong Biotech Ltd. - Ordinary shares

Company Jyong Biotech Ltd. Ordinary Shares

Symbol MENS

Website https://www.jyongbio.com/

Primary Exchange

NASDAQ

ISIN KYG831161065

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Fu-Feng Kuo

Market Capitalization 192 Mio

Country Taiwan

Currency USD

Employees 0,0 T

Address 23F‑3, No. 95, Section 1, Xintai 5th Road, 221 New Taipei City

IPO Date 2025-06-17

Ticker Symbols

Name	Symbol
NASDAQ	MENS

More Shares

Investors who hold Jyong Biotech Ltd. - Ordinary shares also have the following shares in their portfolio:

CASINOS AUSTRIA INT 14-21 Bond

PHILIPPINES 18/28 Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog